Abdominal / Internal Infections

The Problem

Post-operative abdominal and pelvic infections can form abscesses or contaminated cavities that are hard to sterilize using systemic antibiotics alone.

Traditional management (drainage, lavage, and prolonged IV antibiotics) is often insufficient and may lead to recurrence or sepsis.

The GentaGel™ Solution

  • Injectable, moldable matrix conforms to irregular cavities or surgical sites.
  • Controlled local antibiotic release prevents abscess recurrence and secondary infection.
  • Reduces need for repeated interventions and systemic antibiotic exposure.
  • Supports recovery after surgery and reduces postoperative complications.

Market Impact (U.S.)​

~1.0M

Annual cases in the U.S. market

~50K

Complicated infections requiring additional procedures

~30%

Will need more procedures

~$1.0B

Total healthcare costs of these infections in the U.S. market